SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively
16 references·0 citing·33 second hop
Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively (2002)Effects of ayahuasca on sensory and senso…Topographic pharmaco‐EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers (2002)Topographic pharmaco‐EEG mapp…Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers (2001)Subjective effects and tolera…Psychometric assessment of the Hallucinogen Rating Scale☆ (2001)Psychometric assessment of th…Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin (2001)Effects of MDMA (Ecstasy) on …Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat A Pharmacological Analysis and Comparison between Two Rat Strains (2001)Effect of LSD on Prepulse Inh…Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine (1999)Pharmahuasca: Human Pharmacol…Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans (1999)Opposite effects of 3,4-methy…The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans (1998)The Standardized Psychometric…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans (1998)Effects of the hallucinogen p…Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors (1998)Agonist Properties of N,N-Dim…Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Dose-Response Study of N,N-Di…Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex (1989)Hallucinogenic drug interacti…Hallucinogens, cross-cultural perspectives (1984)Hallucinogens, cross-cultural…The Botany and Chemistry of Hallucinogens (1974)The Botany and Chemistry of H…Manual for the State-Trait Anxiety Inventory (1970)Manual for the State-Trait An…Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography (2004)Pharmacology of ayahuasca administered in two repeated doses (2011)PIHKAL: A Chemical Love Story (1991)Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment (2012)Serotonin toxicity of serotonergic psychedelics (2021)Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs (1963)Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens (2011)Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects (2014)A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. (1982)Antagonism of the effects of the hallucinogen dom and the purported 5-HT agonist quipazine by 5-HT2 antagonists (1983)Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans (1996)Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca (2011)Hallucinogenic Drugs and Plants in Psychotherapy and Shamanism (1998)Drug Tourism or Spiritual Healing? Ayahuasca Seekers in Amazonia (2005)The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world (2022)Development and validation of brief measures of positive and negative affect: The PANAS scales. (1988)The benefits of being present: Mindfulness and its role in psychological well-being. (2003)Acceptance and Commitment Therapy: Model, processes and outcomes (2005)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study (2004)Serotonin research: contributions to understanding psychoses (2008)Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory (2019)Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids (2006)The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization (2016)Classical psychedelics for the treatment of depression and anxiety: A systematic review (2019)Hallucinogens and dissociative agents naturally growing in the United States (2004)Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant (2006)Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities (2015)
this work references cited by second hop

References

  • 1970Manual for the State-Trait Anxiety Inventory24,983 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 1998The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans577 cited
  • 1994Dose-Response Study of N,N-Dimethyltryptamine in Humans454 cited
  • 2001Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers302 cited
  • 1974The Botany and Chemistry of Hallucinogens255 cited
  • 1984Hallucinogens, cross-cultural perspectives170 cited
  • 1989Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex152 cited
  • 1998Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors147 cited
  • 1999Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine140 cited
  • 2002Topographic pharmaco‐EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers125 cited
  • 2001Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat A Pharmacological Analysis and Comparison between Two Rat Strains105 cited
  • 2001Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin102 cited
  • 1999

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
97 cited
  • 2001Psychometric assessment of the Hallucinogen Rating Scale☆88 cited
  • 1998Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans80 cited
  • Cited by

    No citing works inside the corpus for this window.